CC
EIDX

Centiva Capital’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Centiva Capital’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,000
Closed -$1.32M – 1607
2020
Q4 		$1.32M Buy
+10,000
New +$884K 0.05% 220

Centiva Capital's EIDX Position: Q1 2021 in Review

Centiva Capital sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 10,000 shares — an estimated $1.32M sold.

Centiva Capital first reported a position in EIDX in Q4 2020 and held it in 1 quarter. The position peaked at $1.32M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • Centiva Capital reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Centiva Capital sold 10,000 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $1.32M.
  • Centiva Capital first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Centiva Capital's Eidos Therapeutics, Inc. Common Stock position peaked at $1.32M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Centiva Capital's 13F filing for Q1 2021, filed 17 May 2021.